Conotoxin-Based Leads in Drug Design

Peptide Drug Discovery and Development: Translational Research in Academia and Industry

Volumn , Issue , 2011, Pages 119-137

  Akcan, Muharrem ^a   Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Conopeptides; Cyclic peptides; NMR; Structure

Indexed keywords

EID: 84887146787     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527636730.ch5     Document Type: Chapter

References (64)

1. Kohn, A.J., Saunders, P.R., and Wiener, S. (1960) Preliminary studies on the venom of the marine snail conus. Ann. NY Acad. Sci., 90 (3), 706-725.
2. Olivera, B.M., Rivier, J., Clark, C., Ramilo, C.A., Corpuz, G.P., Abogadie, F.C., Mena, E.E., Woodward, S.R., Hillyard, D.R., and Cruz, L.J. (1990) Diversity of conus neuropeptides. Science, 249 (4966), 257-263.
3. Terlau, H. and Olivera, B.M. (2004) Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol. Rev., 84 (1), 41-68.
4. Adams, D.J., Alewood, P.F., Craik, D.J., Drinkwater, R.D., and Lewis, R.J. (1999) Conotoxins and their potential pharmaceutical applications. Drug Devel. Res., 46 (3-4), 219-234.
5. Dutton, J.L. and Craik, D.J. (2001) Alpha-conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads. Curr. Med. Chem., 8 (4), 327-344.
6. Halai, R. and Craik, D.J. (2009) Conotoxins: natural product drug leads. Nat. Prod. Rep., 26 (4), 526-536.
7. Olivera, B.M., Gray, W.R., Zeikus, R., McIntosh, J.M., Varga, J., Rivier, J., Desantos, V., and Cruz, L.J. (1985) Peptide neurotoxins from fish-hunting cone snails. Science, 230 (4732), 1338-1343.
8. Mari, F. and Fields, G.B. (2003) Conopeptides: unique pharmacological agents that challenge current peptide methodologies. Chimica Oggi-Chem. Today, 21 (6), 43-48.
9. Kohn, A.J. (1959) The ecology of conus in Hawaii. Ecol. Monog., 29 (1), 47-90.
10. Terlau, H., Shon, K.J., Grilley, M., Stocker, M., Stuhmer, W., and Olivera, B.M. (1996) Strategy for rapid immobilization of prey by a fish-hunting marine snail. Nature, 381 (6578), 148-151.
11. Endean, R., Parish, G., and Gyr, P. (1974) Pharmacology of venom of conus geographus. Toxicon, 12 (12), 131-138.
12. Spence, I., Gillessen, D., Gregson, R.P., and Quinn, R.J. (1977) Characterization of neurotoxic constituents of Conus-Geographus(L) venom, Life Sci., 21, 1759-1769.
13. Woodward, S.R., Cruz, L.J., Olivera, B. M., and Hillyard, D.R. (1990) Constant and hypervariable regions in conotoxin propeptides. Embo J., 9 (4), 1015-1020.
14. Olivera, B.M., Walker, C., Cartier, G.E., Hooper, D., Santos, A.D., Schoenfeld, R., Shetty, R., Watkins, M., Bandyopadhyay, P., and Hillyard, D.R. (1999) Speciation of cone snails and interspecific hyperdivergence of their venom peptides potential-evolutionary significance of introns. Ann. NY Acad. Sci., 870, (Molecular Strategies in Biological Evolution), 223-237.
15. Yuan, D.D., Han, Y.H., Wang, C.G., and Chi, C.W. (2007) From the identification of gene organization of alpha conotoxins to the cloning of novel toxins. Toxicon, 49 (8), 1135-1149.
16. Miljanich, G.P. (2004) Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem., 11 (23), 3029-3040.
17. Rowbotham, M.C., Twilling, L., Davies, P.S., Reisner, L., Taylor, K., and Mohr, D. (2003) Oral opioid therapy for chronic peripheral and central neuropathic pain. New Engl. J. Med., 348 (13), 1223-1232.
18. Canavero, S. and Bonicalzi, V. (2003) Chronic neuropathic pain. New Engl. J. Med., 348 (26), 2688-2689.
19. Basus, V.J., Nadasdi, L., Ramachandran, J., and Miljanich, G.P. (1995) Solution structure of omega-conotoxin MVIIA using 2D NMR-spectroscopy. FEBS Lett., 370 (3), 163-169.
20. Nielsen, K.J., Adams, D., Thomas, L., Bond, T., Alewood, P.F., Craik, D.J., and Lewis, R.J. (1999) Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels. J. Mol. Biol., 289 (5), 1405-1421.
21. Zorn, S., Leipold, E., Hansel, A., Bulaj, G., Olivera, B.M., Terlau, H., and Heinermann, S.H. (2006) The mu O-conotoxin MrVIA inhibits voltagegated sodium channels by associating with domain-3. FEBS Lett., 580 (5), 1360-1364.
22. Jacobsen, R., Stocker, M., Terlau, H., Shon, K., Grilley, M., Gray, W.R., Stuhmer, W., and Olivera, B.M. (1996) Kappa-conotoxin PVIIA, a conus peptide targeted to potassium channels. Soc. Neurosci. Abs., 22 (1-3), 351.
23. Clark, R.J., Fischer, H., Nevin, S.T., Adams, D.J., and Craik, D.J. (2006) The synthesis, structural characterization, and receptor specificity of the alphaconotoxin Vc1.1 J. Biol. Chem., 281 (32), 23254-23263.
24. Bryan-Lluka, L.J., Bonisch, H., and Lewis, R.J. (2003) Chi-conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter. J. Biol. Chem., 278 (41), 40324-40329.
25. Nilsson, K.P.R., Lovelace, E.S., Caesar, C.E., Tynngard, N., Alewood, P.F., Johansson, H.M., Sharpe, I.A., Lewis, R.J., Daly, N.L., and Craik, D.J. (2005) Solution structure of chi-conopeptide MrIA, a modulator of the human norepinephrine transporter. Biopolymers, 80 (6), 815-823.
26. + influx. Proc. Natl. Acad. Sci. USA, 96 (10), 5758-5763.
27. Fainzilber, M., Nakamura, T., Lodder, J.C., Zlotkin, E., Kits, K.S., and Burlingame, A.L. (1998) Gammaconotoxin-PnVIIA, a gammacarboxyglutamate-containing peptide agonist of neuronal pacemaker cation currents. Biochemistry, 37 (6), 1470-1477.
28. Lima, V., Mueller, A., Kamikihara, S.Y., Raymundi, V., Alewood, D., Lewis, R.J., Chen, Z.J., Minneman, K.P., and Pupo, A.S. (2005) Differential antagonism by conotoxin p-TIA of contractions mediated by distinct alpha(1)-adrenoceptor subtypes in rat vas deferens, spleen and aorta. Eur. J. Pharmacol., 508 (1-3), 183-192.
29. England, L.J., Imperial, J., Jacobsen, R., Craig, A.G., Gulyas, J., Akhtar, M., Rivier, J., Julius, D., and Olivera, B.M. (1998) Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails. Science, 281 (5376), 575-578.
30. Miles, L.A., Dy, C.Y., Nielsen, J., Barnham, K.J., Hinds, M.G., Olivera, B.M., Bulaj, G., and Norton, R.S. (2002) Structure of a novel P-superfamily spasmodic conotoxin reveals an inhibitory cystine knot motif. J. Biol. Chem., 277 (45), 43033-43040.
31. Kaas, Q., Westermann, J.C., and Craik, D.J. (2010) Conopeptide characterization and classifications: an analysis using ConoServer. Toxicon, 55 (8), 1491-1509.
32. McDonald, N.Q., Lapatto, R., Murrayrust, J., Gunning, J., Wlodawer, A., and Blundell, T.L. (1991) New protein fold revealed by a 2.3 Å resolution crystal structure of nerve growth factor. Nature, 354 (6352), 411-414.
33. Pallaghy, P.K., Nielsen, K.J., Craik, D.J., and Norton, R.S. (1994) A common structural motif incorporating a cystine knot and a triple stranded beta sheet in toxic and inhibitory polypeptides. Protein Sci., 3 (10), 1833-1839.
34. Isaacs, N.W. (1995) Cystine knots. Curr. Opin. Struct. Biol., 5 (3), 391-395.
35. Craik, D.J., Daly, N.L., and Waine, C. (2001) The cystine knot motif in toxins and implications for drug design. Toxicon, 39 (1), 43-60.
36. Craig, A.G., Bandyopadhyay, P., and Olivera, B.M. (1999) Post-translationally modified neuropeptides from conus venoms. Eur. J. Biochem., 264 (2), 271-275.
37. Clark, R.J., Fischer, H., Dempster, L., Daly, N.L., Rosengren, K.J., Nevin, S.T., Meunier, F.A., Adams, D.J., and Craik, D.J. (2005) Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII. Proc. Natl. Acad. Sci. USA, 102 (39), 13767-13772.
38. Clark, R.J., Jensen, J., Nevin, S.T., Callaghan, B.P., Adams, D.J., and Craik, D.J. (2010) The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew. Chem. Int. Ed. Engl., 49 (37), 6545-6548.
39. Green, B.R., Catlin, P., Zhang, M.M., Fiedler, B., Bayudan, W., Morrison, A., Norton, R.S., Smith, B.J., Yoshikami, D., Olivera, B.M., and Bulaj, G. (2007) Conotoxins containing nonnatural backbone spacers: cladistic-based design, chemical synthesis, and improved analgesic activity. Chem. Biol., 14 (4), 399-407.
40. Blanchfield, J., Dutton, J., Hogg, R., Craik, D., Adams, D., Lewis, R., Alewood, P., and Toth, I. (2001) The synthesis and structure of an N-terminal dodecanoic acid conjugate of alphaconotoxin MII. Lett. Pept. Sci., 8 (3-5), 235-239.
41. Nishiuchi, Y. and Sakakibara, S. (1982) Primary and secondary structure of conotoxin GI, a neurotoxic tridecapeptide from a marine snail. FEBS Lett., 148 (2), 260-262.
42. Gray, W.R., Rivier, J.E., Galyean, R., Cruz, L.J., and Olivera, B.M. (1983) Conotoxin-MI-disulfide bonding and conformational states. J. Biol. Chem., 258 (20), 2247-2251.
43. Nishiuchi, Y., Kumagaye, K., Noda, Y., Watanabe, T.X., and Sakakibara, S. (1986) Synthesis and secondary structure determination of omegaconotoxin GVIA-A 27-peptide with 3 intramolecular disulfide bonds. Biopolymers, 25, S61-S68.
44. Merrifield, R.B. (1963) Solid phase peptide synthesis. 1. Synthesis of a tetrapeptide, J. Am. Chem. Soc., 85, 2149-2154.
45. Merrifield, R.B. (1964) Solid phase peptide synthesis. 2. Synthesis of bradykinin, J. Am. Chem. Soc., 86, 304-305.
46. Carpino, L.A. and Han, G.Y. (1972) 9-Fluorenylmethoxycarbonyl aminoprotecting group, J. Org. Chem., 37, 3404-3409.
47. Schnölzer, M., Alewood, P., Jones, A., Alewood, D., and SBH, K. (2007) In situ neutralization in Boc-chemistry solid phase peptide synthesis: rapid, high yield assembly of difficult sequences. Int. J. Peptide Res. Ther., 13 (1-2), 31-44.
48. Bulaj, G. and Olivera, B.M. (2008) Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of conus peptides. Antiox. Redox Signal., 10 (1), 141-155.
49. Marx, U.C., Daly, N.L., and Craik, D.J. (2006) NMR of conotoxins: structural features and an analysis of chemical shifts of post-translationally modified amino acids. Magn. Reson. Chem., 44, S41-S50.
50. Franco, A. and Mari, F. (1999) Threedimensional structure of alpha-conotoxin EI determined by H-1 NMR spectroscopy. Lett. Peptide Sci., 6 (4), 199-207.
51. Hu, S.H., Gehrmann, J., Guddat, L.W., Alewood, P.F., Craik, D.J., and Martin, J.L. (1996) The 1.1 angstrom crystal structure of the neuronal acetylcholine receptor antagonist, alpha-conotoxin PnIA from Conus pennaceus. Structure, 4 (4), 417-423.
52. Guddat, L.W., Martin, J.L., Shan, L., Edmundson, A.B., and Gray,W.R. (1996) Three-dimensional structure of the alphaconotoxin GI at 1.2 angstrom resolution. Biochemistry, 35 (35), 11329-11335.
53. Ulens, C., Hogg, R.C., Celie, P.H., Bertrand, D., Tsetlin, V., Smit, A.B., and Sixma, T.K. (2006) Structural determinants of selective alphaconotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. Proc. Natl. Acad. Sci. USA, 103 (10), 3615-3620.
54. Olivera, B.M., Cruz, L.J., Desantos, V., Lecheminant, G.W., Griffin, D., Zeikus, R., McIntosh, J.M., Galyean, R., Varga, J., Gray, W.R., and Rivier, J. (1987) Neuronal Ca channel antagonists. Discrimination between Ca channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry, 26 (8), 2086-2090.
55. Adams, D.J., Smith, A.B., Schroeder, C.I., Yasuda, T., and Lewis, R.J. (2003) Omega-conotoxin CVID inhibits a pharmacologically distinct voltage sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J. Biol. Chem., 278 (6), 4057-4062.
56. Vincler, M., Wittenauer, S., Parker, R., Ellison, M., Olivera, B.M., and McIntosh, J.M. (2006) Molecular mechanism for analgesia involving specific antagonism of alpha 9 alpha 10 nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. USA, 103 (47), 17880-17884.
57. Nevin, S.T., Clark, R.J., Klimis, H., Christie, M.J., Craik, D.J., and Adams, D.J. (2007) Are alpha 9 alpha 10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins? Mol. Pharmacol., 72 (6), 1406-1410.
58. Callaghan, B., Haythornthwaite, A., Berecki, G., Clark, R.J., Craik, D.J., and Adams, D.J. (2008) Analgesic alphaconotoxins Vc1.1 and Rg1A inhibit Ntype calcium channels in rat sensory neurons via GABA(B) receptor activation. J. Neurosci., 28 (43), 10943-10951.
59. Callaghan, B. and Adams, D.J. (2010) Analgesic alpha-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of alpha 9 nicotinic receptor knockout mice. Channels, 4 (1), 51-54.
60. Sandall, D.W., Satkunanathan, N., Keays, D.A., Polidano, M.A., Liping, X., Pham, V., Down, J.G., Khalil, Z., Livett, B.G., and Gayler, K.R. (2003) A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. Biochemistry, 42 (22), 6904-6911.
61. Satkunanathan, N., Livett, B., Gayler, K., Sandall, D., Down, J., and Khalil, Z. (2005) Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones. Brain Res., 1059 (2), 149-158.
62. Nielsen, C.K., Lewis, R.J., Alewood, D., Drinkwater, R., Palant, E., Patterson, M., Yaksh, T.L., McCumber, D., and Smith, M.T. (2005) Anti-allodynic efficacy of the chi-conopeptide, Xen2174, in rats with neuropathic pain. Pain, 118 (1-2), 112-124.
63. Brust, A., Palant, E., Croker, D.E., Colless, B., Drinkwater, R., Patterson, B., Schroeder, C.I., Wilson, D., Nielsen, C.K., Smith, M.T., Alewood, D., Alewood, P.F., and Lewis, R.J. (2009) Chi-conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain. J. Med. Chem., 52 (22), 6991-7002.
64. Craik, D.J. (2006) Chemistry-seamless proteins tie up their loose ends. Science, 311 (5767), 1563-1564.